Drug Shortage Report for CEFTRIAXONE INJECTION, USP
| Report ID | 235267 |
| Drug Identification Number | 02499711 |
| Brand name | CEFTRIAXONE INJECTION, USP |
| Common or Proper name | Ceftriaxone Injection |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTRIAXONE |
| Strength(s) | 1000MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | CA2G3504– 24 bags/case |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2024-08-15 |
| Actual start date | 2024-08-15 |
| Estimated end date | 2024-08-23 |
| Actual end date | 2024-08-23 |
| Shortage status | Resolved |
| Updated date | 2024-08-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-08-24 | English | Compare |
| v5 | 2024-08-23 | French | Compare |
| v4 | 2024-08-23 | English | Compare |
| v3 | 2024-08-16 | English | Compare |
| v2 | 2024-08-15 | French | Compare |
| v1 | 2024-08-15 | English | Compare |
Showing 1 to 6 of 6